Dental Devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative interventions. Dental Lasers are lasers that are specifically designed for use in dental surgeries. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dental lasers devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the dental lasers market in New Zealand was Biolase followed by DEKA M.E.L.A., Dentsply Sirona, AMD Lasers, FOTONA proizvodnja optoelektronskih naprav, elexxion, J. Morita Mfg. and Den-Mat Holdings.
Dental Lasers are classified into two types: Dental Surgical Lasers and Dental Welding Lasers. Surgical Lasers are the lasers that are directly used for dental surgical processes intraorally. In dentistry, Welding lasers are used to apply welds between abutment elements during construction of the metal framework or after ceramics application.
The value of the dental lasers devices market within New Zealand was expected to be over $9m in 2023.
For the latest complete market share analysis of dental lasers device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
